california semaglutide ban Critics debate banning GLP-1 weight-loss medications in sports for their potential as performance enhancers. link in bio ๐ Novo Nordisk expands legal action
Description
The specific SAEs that were documented included events such as gastrointestinal complications, infections, and cardiovascular-related issues
Here are the key side effect findings from the published data: The Phase 2 trial, published in the New England Journal of Medicine in 2023, enrolled 338 adults and tested doses from 1mg to 12mg
Some people report reduced hunger or less "food noise" (constant background thoughts about food) within the first few days
Eating 130 grams of protein when you are not hungry is genuinely difficult
Causes of and Treatments for Excessive Sweating Excessive sweating (hyperhidrosis) can soak shirts and erode confidence, but it is highly treatable
